## Protocol Section
### Identification Module
**NCT ID:** NCT00037479

**Brief Title:** Brain Imaging and Retreatment Study of Persistent Lyme Disease

**Official Title:** PET and MRI Imaging of Persistent Lyme Encephalopathy

#### Organization Study ID Info
**ID:** R01NS038636
**Link:** https://reporter.nih.gov/quickSearch/R01NS038636
**Type:** NIH
#### Organization
**Class:** NIH
**Full Name:** National Institute of Neurological Disorders and Stroke (NINDS)
### Status Module
#### Expanded Access Info
#### Last Update Post Date
**Date:** 2005-12-07

**Type:** ESTIMATED

**Last Update Submit Date:** 2005-12-06

**Overall Status:** COMPLETED

#### Start Date
**Date:** 1999-12

**Status Verified Date:** 2005-12

#### Study First Post Date
**Date:** 2002-05-20
**Type:** ESTIMATED
**Study First Submit Date:** 2002-05-17
**Study First Submit QC Date:** 2002-05-17
### Sponsor Collaborators Module

#### Lead Sponsor

**Class:** NIH

**Name:** National Institute of Neurological Disorders and Stroke (NINDS)

### Description Module

**Brief Summary:** The purpose of this study is to determine whether patients with persistent memory problems after Lyme disease benefit from an additional longer course of IV antibiotic therapy; to use modern brain imaging technology to determine whether the problem in the central nervous system is primarily one of poor blood flow or one of impaired nerve cell functioning; and to try to identify biological markers prior to treatment that will identify patients who are more or less likely to respond to the study treatment.

**Detailed Description:** Some people with a history of Lyme disease continue to have problems despite having received "textbook duration" antibiotic therapy. When memory, attention, or thinking problems persist, the syndrome is called persistent Lyme disease (PLD). This study seeks to answer critical scientific questions about the treatment and cause of PLD symptoms.

This 24-week treatment study will evaluate each patient's response to treatment using neuropsychological testing and state-of-the-art brain imaging. The brain tests include neuropsychological testing of memory and attention, brain imaging (MRI and PET scans) to look at blood flow in the brain and nerve cell structure and metabolism, a neurological exam, and studies of the fluid that surrounds the brain (cerebrospinal fluid). The treatment involves 10 weeks of either intravenous antibiotic called ceftriaxone (also known as Rocephin) or intravenous placebo (inactive substance). After the first visit to Columbia Presbyterian Medical Center, the remaining treatments will be done in the patient's home. Patients will be screened over the phone and in person to confirm study eligibility.

### Conditions Module

**Conditions:**

- Lyme Disease

- Lyme Neuroborreliosis

**Keywords:**

- neurologic Lyme disease

- Lyme disease

- ceftriaxone

- Rocephin

- PET scans

- Lyme encephalopathy

- neuroborreliosis

- borreliosis

### Design Module

#### Design Info

**Allocation:** RANDOMIZED

**Primary Purpose:** TREATMENT

#### Enrollment Info

**Count:** 65

**Phases:**

- PHASE2

**Study Type:** INTERVENTIONAL

### Arms Interventions Module

### Interventions

#### Intervention 1

**Name:** ceftriaxone

**Type:** DRUG

### Eligibility Module

**Eligibility Criteria:** Inclusion Criteria:

Eligible participants must:

* Be 18-65 years old
* Have persistent problems with memory, verbal fluency, or attention after having contracted Lyme disease.
* Be able to travel to New York for 4-5 evaluations over the course of one year. Travel costs for participants in need may be partially or fully reimbursable.
* Have had a history of well-documented Lyme disease using the CDC's clinical criteria and a current positive IgG Western blot or PCR.
* Have received, at some point in the past at least 3 weeks of IV antibiotic therapy for Lyme disease.

Exclusion Criteria:

Ineligible from participation are people with the following:

* Other major medical or neurologic problems
* Smoke more than 10 cigarettes a day
* Uncontrolled high blood pressure
* Allergy to ceftriaxone (Rocephin)
* History of marked cocaine abuse

Twenty healthy subjects are also being sought for the study.

**Healthy Volunteers:** True

**Maximum Age:** 65 Years

**Minimum Age:** 18 Years

**Sex:** ALL

**Standard Ages:**

- ADULT

- OLDER_ADULT

### Contacts Locations Module

#### Locations

**Location 1:**

**City:** New York

**Country:** United States

**Facility:** Columbia Presbyterian Medical Center

**State:** New York

**Zip:** 10032

#### Overall Officials

**Official 1:**

**Affiliation:** Columbia University, College of Physicians and Surgeons, Lyme Disease Research Program

**Name:** Brian Fallon, M.D.

**Role:** PRINCIPAL_INVESTIGATOR

### References Module

#### See Also Links

**Label:** Columbia's Lyme disease research studies website

**URL:** http://www.columbia-lyme.org

## Derived Section

### Condition Browse Module - Ancestors

- ID: D000016905

- Term: Gram-Negative Bacterial Infections

- ID: D000001424

- Term: Bacterial Infections

- ID: D000001423

- Term: Bacterial Infections and Mycoses

- ID: D000007239

- Term: Infections

- ID: D000001899

- Term: Borrelia Infections

- ID: D000013145

- Term: Spirochaetales Infections

- ID: D000017282

- Term: Tick-Borne Diseases

- ID: D000079426

- Term: Vector Borne Diseases

- ID: D000020806

- Term: Central Nervous System Bacterial Infections

- ID: D000002494

- Term: Central Nervous System Infections

- ID: D000002493

- Term: Central Nervous System Diseases

- ID: D000009422

- Term: Nervous System Diseases

### Condition Browse Module - Browse Branches

- Abbrev: BC01

- Name: Infections

- Abbrev: All

- Name: All Conditions

- Abbrev: BC10

- Name: Nervous System Diseases

- Abbrev: BC23

- Name: Symptoms and General Pathology

### Condition Browse Module - Browse Leaves

- ID: M11190

- Name: Lyme Disease

- Relevance: HIGH

- As Found: Lyme Disease

- ID: M22602

- Name: Lyme Neuroborreliosis

- Relevance: HIGH

- As Found: Lyme Neuroborreliosis

- ID: M5177

- Name: Borrelia Infections

- Relevance: LOW

- As Found: Unknown

- ID: M10283

- Name: Infections

- Relevance: LOW

- As Found: Unknown

- ID: M6368

- Name: Communicable Diseases

- Relevance: LOW

- As Found: Unknown

- ID: M4722

- Name: Bacterial Infections

- Relevance: LOW

- As Found: Unknown

- ID: M19249

- Name: Gram-Negative Bacterial Infections

- Relevance: LOW

- As Found: Unknown

- ID: M12136

- Name: Mycoses

- Relevance: LOW

- As Found: Unknown

- ID: M4721

- Name: Bacterial Infections and Mycoses

- Relevance: LOW

- As Found: Unknown

- ID: M19577

- Name: Tick-Borne Diseases

- Relevance: LOW

- As Found: Unknown

- ID: M2054

- Name: Vector Borne Diseases

- Relevance: LOW

- As Found: Unknown

- ID: M22561

- Name: Central Nervous System Bacterial Infections

- Relevance: LOW

- As Found: Unknown

- ID: M5743

- Name: Central Nervous System Infections

- Relevance: LOW

- As Found: Unknown

- ID: M5742

- Name: Central Nervous System Diseases

- Relevance: LOW

- As Found: Unknown

### Condition Browse Module - Meshes

- ID: D000008193

- Term: Lyme Disease

- ID: D000020852

- Term: Lyme Neuroborreliosis

### Intervention Browse Module - Ancestors

- ID: D000097911

- Term: Third Generation Cephalosporins

- ID: D000097902

- Term: Beta Lactam Antibiotics

- ID: D000000900

- Term: Anti-Bacterial Agents

- ID: D000000890

- Term: Anti-Infective Agents

### Intervention Browse Module - Browse Branches

- Abbrev: Infe

- Name: Anti-Infective Agents

- Abbrev: All

- Name: All Drugs and Chemicals

### Intervention Browse Module - Browse Leaves

- ID: M5693

- Name: Ceftriaxone

- Relevance: HIGH

- As Found: Antimicrobial

- ID: M5760

- Name: Cephalosporins

- Relevance: LOW

- As Found: Unknown

- ID: M3453

- Name: Third Generation Cephalosporins

- Relevance: LOW

- As Found: Unknown

- ID: M4222

- Name: Anti-Bacterial Agents

- Relevance: LOW

- As Found: Unknown

- ID: M10789

- Name: Lactams

- Relevance: LOW

- As Found: Unknown

- ID: M25772

- Name: beta-Lactams

- Relevance: LOW

- As Found: Unknown

- ID: M4224

- Name: Antibiotics, Antitubercular

- Relevance: LOW

- As Found: Unknown

- ID: M3444

- Name: Beta Lactam Antibiotics

- Relevance: LOW

- As Found: Unknown

- ID: M4214

- Name: Anti-Infective Agents

- Relevance: LOW

- As Found: Unknown

### Intervention Browse Module - Meshes

- ID: D000002443

- Term: Ceftriaxone

### Misc Info Module

- Version Holder: 2024-05-24
